Literature DB >> 22848252

Prevalence of human papillomavirus in university young women.

Maria T Montalvo1, Ismelda Lobato, Hilda Villanueva, Celia Borquez, Daniela Navarrete, Juan Abarca, Gloria M Calaf.   

Abstract

Cervical cancer is the second most prevalent female cancer worldwide. The majority of cases appear between the age of 30 and 50. Human papillomavirus (HPV) plays a central role in cervical cancer with 99.7% of HPV DNA identified in invasive cervical carcinomas. The prevalence of the HPV infection varies substantially among countries and according to age and lifestyle. HPV is a common sexually transmitted infection among males and females with a 70% higher incidence in sexually active females. This study aimed to determine the prevalence of human papillomavirus in young university women by analyzing the correlation between Papanicolaou (PAP)-stained cervical tests and HPV detection by genotyping, as well as other risk factors. A total of 200 women aged between 18 and 25 years were enrolled in this study, which took place between September 2008 and May 2009 at the Universidad de Tarapacá, Arica, Chile. Results of the PAP smears showed that 97.5% of cells had normal characteristics, although an inflammatory pattern was noted. The prevalence of generic HPV infection was 3.5% when testing for HPV DNA using the polymerase chain reaction (PCR) method. An analysis of the genotype of infected female individuals indicated that high-risk HPV types, such as HPV 16 and 31 were present in 42.84 and 14.29% of females, respectively, and low-risk types such as HPV 6, in 14.29%. Only one sample with differentiated non-HPV (14.29%) was found. A 95% correlation between PAP-stained cervical tests and the method of testing for HPV was observed. Using the PCR method, it was found that of the 195 negative PAP smears, 5 were positive for HPV and two of the samples that were positive for ASC-US were also positive. A significantly increased (P<0.05) HPV infection risk was observed in the 18-21 age group with a higher prevalence (71.40%) when compared to the 22-25 age group (28.6%). A significant (P<0.042) difference was found between smoking and HPV infection. In conclusion, a significant (P<0.05) correlation was found between PAP and PCR methods for HPV testing in young university women. A significant correlation between smoking and HPV was detected, whereas no difference was noted with other parameters.

Entities:  

Year:  2011        PMID: 22848252      PMCID: PMC3406457          DOI: 10.3892/ol.2011.290

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

Review 1.  Clinical utility of HPV genotyping.

Authors:  Chris J Meijer; Peter J Snijders; Philip E Castle
Journal:  Gynecol Oncol       Date:  2006-08-24       Impact factor: 5.482

2.  Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile.

Authors:  Catterina Ferreccio; Rodrigo B Prado; Amaranta V Luzoro; Sandra Ll Ampuero; Peter J F Snijders; Chris J L M Meijer; Salvatore V Vaccarella; Alejandro T Jara; Klaus I Puschel; Sylvia C Robles; Rolando Herrero; Silvia F Franceschi; Jose M Ojeda
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

3.  Longitudinal study of the effects of pregnancy and other factors on detection of HPV.

Authors:  J Chang-Claude; A Schneider; E Smith; M Blettner; J Wahrendorf; L Turek
Journal:  Gynecol Oncol       Date:  1996-03       Impact factor: 5.482

4.  Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study.

Authors:  J Berumen; R M Ordoñez; E Lazcano; J Salmeron; S C Galvan; R A Estrada; E Yunes; A Garcia-Carranca; G Gonzalez-Lira; A Madrigal-de la Campa
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

5.  Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers.

Authors:  Byeong-Sun Choi; Okjin Kim; Mi Sun Park; Ki Soo Kim; Jeongmi Kim Jeong; Joo-Shil Lee
Journal:  J Med Virol       Date:  2003-11       Impact factor: 2.327

6.  Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil.

Authors:  Geni N L Camara; Daniela M Cerqueira; Ana P G Oliveira; Evandro O Silva; Luciano G S Carvalho; Cláudia R F Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-01-07       Impact factor: 2.743

7.  Detection rates for abnormal cervical smears: what are we screening for?

Authors:  A E Raffle; B Alden; E F Mackenzie
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

8.  Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.

Authors:  L Kjellberg; G Hallmans; A M Ahren; R Johansson; F Bergman; G Wadell; T Angström; J Dillner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.

Authors:  J O Thomas; R Herrero; A A Omigbodun; K Ojemakinde; I O Ajayi; A Fawole; O Oladepo; J S Smith; A Arslan; N Muñoz; P J F Snijders; C J L M Meijer; S Franceschi
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

10.  Prevalence and determinants of HPV infection among Colombian women with normal cytology.

Authors:  M Molano; H Posso; E Weiderpass; A J C van den Brule; M Ronderos; S Franceschi; C J L M Meijer; A Arslan; N Munoz
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more
  2 in total

1.  Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.

Authors:  Monserrat Balanda; Andrea Quiero; Nicolás Vergara; Gloria Espinoza; Héctor San Martín; Giovanna Rojas; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2016-08-18       Impact factor: 3.402

Review 2.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.